Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Brooklyn ImmunoTherapeutics, Inc. - Common Stock (NY:BTX)

6.730 -0.030 (-0.44%)
Official Closing Price Updated: 7:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 512,781
Open 6.630
Bid (Size) 6.530 (1,000)
Ask (Size) 6.830 (3,100)
Prev. Close 6.760
Today's Range 6.545 - 6.790
52wk Range 5.100 - 7.500
Shares Outstanding 7,848,889
Dividend Yield 9.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire

Performance

YTD
+0.6%
+0.6%
1 Month
+2.6%
+2.6%
3 Month
+0.6%
+0.6%
6 Month
-3.4%
-3.4%
1 Year
+7.5%
+7.5%

More News

Read More
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
BlackRock Technology and Private Equity Term Trust Maintains Payouts, But Return of Capital Raises Investor Eyebrows
Via MarketMinute
Topics Initial Public Offering
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
BlackRock Announces Update to BMEZ, BSTZ, and BTX Managed Distribution Plans
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Sector Equity Closed-End Funds Announce Updates to Investment Objectives and Principal Investment Strategies
From BlackRock Closed-End Funds
Via Business Wire
News headline image
BlackRock Technology and Private Equity Term Trust (BTX) Announces Final Results of Tender Offer
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
BlackRock Technology and Private Equity Term Trust (BTX) Announces Expiration and Preliminary Results of Tender Offer
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
News headline image
BlackRock Technology and Private Equity Term Trust (BTX) Commences Tender Offer for up to 50% of outstanding common shares
From BlackRock Closed-End Funds
Via Business Wire
News headline image
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire

Frequently Asked Questions

Is Brooklyn ImmunoTherapeutics, Inc. - Common Stock publicly traded?
Yes, Brooklyn ImmunoTherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Brooklyn ImmunoTherapeutics, Inc. - Common Stock trade on?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock is BTX on the New York Stock Exchange
What is the current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 6.730
When was Brooklyn ImmunoTherapeutics, Inc. - Common Stock last traded?
The last trade of Brooklyn ImmunoTherapeutics, Inc. - Common Stock was at 04/02/26 07:00 PM ET
What is the market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 52.82M
How many shares of Brooklyn ImmunoTherapeutics, Inc. - Common Stock are outstanding?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock has 53M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.